f Nuclei-targeted Therapeutic Delivery: A Novel Concept for the Treatment of Cancer

References

1. Saklani S. Recent Patterns of Cancer Incidence and Mortality. Global and Indian Scenario. Nanoparticles in Cancer Theranostics CRC Press Boca Raton, FL 2024 40 52
   [Google Scholar]
2. Fu X. Shi Y. Qi T. Qiu S. Huang Y. Zhao X. Sun Q. Lin G. Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Signal Transduct. Target. Ther. 2020 5 1 262 10.1038/s41392‑020‑00342‑0 33154350
   [Google Scholar]
3. Roy S.M. Garg V. Sivaraman S.P. Barman S. Ghosh C. Bag P. Mohanasundaram P. Maji P.S. Basu A. Dirisala A. Ghosh S.K. Maity A.R. Overcoming the barriers of nuclear-targeted drug delivery using nanomedicine-based strategies for enhanced anticancer therapy. J. Drug Deliv. Sci. Technol. 2023 83 104408 10.1016/j.jddst.2023.104408
   [Google Scholar]
4. Huynh M. Vinck R. Gibert B. Gasser G. Strategies for the nuclear delivery of metal complexes to cancer cells. Adv. Mater. 2024 36 16 2311437 10.1002/adma.202311437 38174785
   [Google Scholar]
5. Sakiyama Y. Mazur A. Kapinos L.E. Lim R.Y.H. Spatiotemporal dynamics of the nuclear pore complex transport barrier resolved by high-speed atomic force microscopy. Nat. Nanotechnol. 2016 11 8 719 723 10.1038/nnano.2016.62 27136131
   [Google Scholar]
6. Goyal P. Malviya R. Advances in nuclei targeted delivery of nanoparticles for the management of cancer. Biochim. Biophys. Acta Rev. Cancer 2023 1878 3 188881 10.1016/j.bbcan.2023.188881 36965678
   [Google Scholar]
7. Xia W. Tao Z. Zhu B. Zhang W. Liu C. Chen S. Song M. Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy. Int. J. Mol. Sci. 2021 22 17 9118 10.3390/ijms22179118 34502028
   [Google Scholar]
8. Zhang J. Huang L. Ge G. Hu K. Emerging epigenetic‐based nanotechnology for cancer therapy: Modulating the tumor microenvironment. Adv. Sci. 2023 10 7 2206169 10.1002/advs.202206169 36599655
   [Google Scholar]
9. Nie Y. Fu G. Leng Y. Nuclear delivery of nanoparticle-based drug delivery systems by nuclear localization signals. Cells 2023 12 12 1637 10.3390/cells12121637 37371107
   [Google Scholar]
10. Li N. Yang H. Yu Z. Li Y. Pan W. Wang H. Tang B. Nuclear-targeted siRNA delivery for long-term gene silencing. Chem. Sci. 2017 8 4 2816 2822 10.1039/C6SC04293G 28553519
    [Google Scholar]
11. Lu J. Wu T. Zhang B. Liu S. Song W. Qiao J. Ruan H. Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun. Signal. 2021 19 1 60 10.1186/s12964‑021‑00741‑y 34022911
    [Google Scholar]
12. Xu D. Farmer A. Chook Y.M. Recognition of nuclear targeting signals by Karyopherin-β proteins. Curr. Opin. Struct. Biol. 2010 20 6 782 790 10.1016/j.sbi.2010.09.008 20951026
    [Google Scholar]
13. Zhao J. Zhao F. Wang X. Fan X. Wu G. Secondary nuclear targeting of mesoporous silica nano-particles for cancer-specific drug delivery based on charge inversion. Oncotarget 2016 7 43 70100 70112 10.18632/oncotarget.12149 27661121
    [Google Scholar]
14. Jain S. Hirst D.G. O’Sullivan J.M. Gold nanoparticles as novel agents for cancer therapy. Br. J. Radiol. 2012 85 1010 101 113 10.1259/bjr/59448833 22010024
    [Google Scholar]
15. Watermann A. Brieger J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials 2017 7 7 189 10.3390/nano7070189 28737672
    [Google Scholar]
16. Zhao Y. Yue P. Peng Y. Sun Y. Chen X. Zhao Z. Han B. Recent advances in drug delivery systems for targeting brain tumors. Drug Deliv. 2023 30 1 1 18 10.1080/10717544.2022.2154409 36597214
    [Google Scholar]
17. Yao J. Fan Y. Li Y. Huang L. Strategies on the nuclear-targeted delivery of genes. J. Drug Target. 2013 21 10 926 939 10.3109/1061186X.2013.830310 23964565
    [Google Scholar]
18. Sarikhani E. Patel V. Li Z. Meganathan D.P. Rahmani K. Sadr L. Hosseini R. Visda D. Shukla S. Naghsh-Nilchi H. Balaji A. McMahon G. Chen S. Schöneberg J. McHugh C.A. Shi L. Jahed Z. Engineered nanotopographies induce transient openings in the nuclear membrane. Adv. Funct. Mater. 2025 35 6 2410035 10.1002/adfm.202410035
    [Google Scholar]